Drug interactions
Buprenorphine subdermal implant + Carisoprodol
Severity: Major
Buprenorphine subdermal implant and Carisoprodol: major interaction.
Last updated Sources: US FDA label
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Buprenorphine, even as a low-fluctuation implant, depresses the CNS and respiration, and carisoprodol adds sedation. Concurrent use increases the risk of profound sedation, respiratory depression and death.
What this interaction means in plain words
Buprenorphine subdermal implant and Carisoprodol can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Additive CNS and respiratory depression.
What to do
Avoid unless no alternatives exist, and monitor for sedation and respiratory depression. Counsel patients and caregivers about warning signs.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine subdermal implant and Carisoprodol, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
References
Other interactions of Carisoprodol
Frequently asked questions
Can I take Buprenorphine subdermal implant with Carisoprodol?
MediHelp rates the interaction as major. Buprenorphine subdermal implant and Carisoprodol can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Buprenorphine, even as a low-fluctuation implant, depresses the CNS and respiration, and carisoprodol adds sedation. Concurrent use increases the risk of profound sedation, respiratory depression and death.
How serious is the interaction between Buprenorphine subdermal implant and Carisoprodol?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid unless no alternatives exist, and monitor for sedation and respiratory depression. Counsel patients and caregivers about warning signs.
What other medicines interact with Carisoprodol?
MediHelp also lists interactions of Carisoprodol with, for example, Alfentanil, Alprazolam, Amobarbital. The full list is on the Carisoprodol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
